simvastatin has been researched along with Carditis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Haczkiewicz-Leśniak, K; Kwiatkowska, J; Piasecki, T; Podhorska-Okołów, M; Sapa-Wojciechowska, A; Skrzypiec-Spring, M; Szeląg, A | 1 |
| Małyszko, J; Małyszko, JS; Myśliwiec, M; Pawlak, K; Stogowska-Nikiciuk, B | 1 |
| Huang, H; Jing, H; Li, D; Shao, H; Shen, Y; Wang, C; Wu, H | 1 |
| Cheng, CF; Cheng, WT; Kikuchi, T; Lian, WS; Lin, H | 1 |
| Almeida-Leite, CM; Bahia, MT; Leite, R; Shrestha-Bajracharya, D; Silva, RR; Talvani, A | 1 |
| Fu, M; Katsuda, S; Matsui, S; Nishikawa, K; Sun, BG; Wu, JL; Zong, ZP | 1 |
1 trial(s) available for simvastatin and Carditis
| Article | Year |
|---|---|
[The influence of simvastatin on hsCRP and some paramneters of hemostasis in patients with ischemic heart disease].
Topics: Aged; C-Reactive Protein; Carboxypeptidase B2; Cholesterol; Cholesterol, LDL; Female; Hemostasis; Humans; Male; Myocardial Ischemia; Myocarditis; Simvastatin; Thrombomodulin; Triglycerides | 2008 |
5 other study(ies) available for simvastatin and Carditis
| Article | Year |
|---|---|
HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation.
Topics: Animals; Autoimmune Diseases; Cardiotonic Agents; Echocardiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Metalloproteases; Models, Animal; Myocarditis; Rats; Simvastatin; Ventricular Dysfunction, Left | 2021 |
Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor γ.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiopulmonary Bypass; Cardiotonic Agents; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Heart; Inflammation Mediators; Male; Myocardial Reperfusion Injury; Myocarditis; Myocardium; Neutrophil Infiltration; NF-kappa B; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Simvastatin; Up-Regulation | 2010 |
Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrosis; Granulocyte Colony-Stimulating Factor; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Thrombosis; Tirofiban; Tyrosine | 2011 |
Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Disease Models, Animal; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats.
Topics: Animals; Anti-Inflammatory Agents; Antigen-Presenting Cells; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cell Communication; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocarditis; Rats; Rats, Inbred Lew; Simvastatin; Spleen; Swine; Tumor Necrosis Factor-alpha | 2008 |